// App-Quantinova.ai

4504 : Mature results of the GETUG 13 phase III trial in poor-prognosis germ-cell tumors

Researchers

Presenter

  • Karim Fizazi

Principal Investigators

  • Gwenael / Le Teuff

  • Jozef Mardiak

  • Lance C. Pagliaro

  • Lionnel Geoffrois

  • Pierre Kerbrat

  • Christine Chevreau

  • Remy Delva

  • Frederic Rolland

  • Christine Theodore

  • Guilhem Roubaud

  • Gwenaelle Gravis

  • Jean-Christophe Eymard

  • Jean-pierre Malhaire

  • Claude Linassier

  • Muriel Habibian

  • Maria Reckova

  • Christopher Logothetis

  • Stephane Culine

Medical Centers

  • Institut Gustave Roussy, University of Paris Sud, Villejuif, France

  • Centre Leon Berard, Lyon, France

  • Gustave Roussy, Villejuif, France

  • Department of Clinical Oncology, National Cancer Institute, Commenius University, Bratislava, Slovakia

  • The University of Texas MD Anderson Cancer Canter, Houston, TX

  • Centre Alexis Vautrin, Vandoeuvre-Les-Nancy, France

  • Medical Oncology Eugene Marquis Comprehensive Cancer Center, Rennes, France

  • Institut Claudius Regaud, Toulouse, France

  • Institut de Cancerologie de l'Ouest Paul Papin, Angers, France

  • Centre Rene Gauducheau, Saint-Herblain, France

  • Hospital Foch, Suresnes, France

  • Department of Medical Oncology - Institut Bergonie, Bordeaux, France

  • Medical Oncology, Institut Paoli Calmette, Hopital de Jour, Marseille, France

  • Institut Jean-Godinot, Reims, France

  • Centre Hospitalo-Universitaire, Brest, France

  • Oncologie Medicale, Tours, France

  • UNICANCER, Paris, France

  • Department of Medical Oncology, Hopital Saint-Louis, Paris, France

Locations

  • France

  • Slovakia

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Germ cell tumor

Biomarkers

  • Alpha-fetoprotein

  • Chorionic Gonadotropin Subunit Beta 5

  • Granulocyte colony-stimulating factor

Drug/Treatment

  • Oxaliplatin

  • Ifosfamide

  • Paclitaxel

  • Cisplatin

  • Bleomycin

  • Filgrastim

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • III

Study Id's

  • NCT00104676

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved